Table 2.

Characteristics of patients with and without sarcopenia

	Total		Sarcopenic		Non sarcopenic		χ2	p value
	N = 73		N = 24		N = 49
Age (years) (M, SD)	81.73	6.24(SD)	83.7	5.73(SD)	80.24	6.21(SD)	NA	0.025
Sex (n, %)
Male	33	45	10	42	23	47	0.181	0.671
Female	40	55	14	58	26	53
Weight loss 6 months prior to diagnosis (n, %)
Non	46	63	15	63	31	63	0.392	0.822
< 10%	20	27	6	25	14	29
≥ 10%	7	10	3	13	4	8
BMI (kg/m2)	26.80	5.70(SD)	25.12	4.99(SD)	27.92	4.49(SD)	NA	0.018
Smoker (n, %)
No	25	34	11	46	14	29	2.604	0.272
Former	40	55	10	42	30	61
Current	8	11	3	13	5	10
MUST score (n, %)
0	53	72	18	75	35	71	0.533	0.766
1	1	2	0	0	1	2
2	19	26	6	25	13	27
Alcohol use (n, %)
No	25	34	9	38	16	33	1.340	0.720
Yes	41	56	14	58	27	55
Former	7	10	1	4	6	12
Charlson comorbidity index (n, %)
Low ≤ 6	27	37	6	25	21	43	2.204	0.138
High > 6	46	63	18	75	28	57
Localization (n, %)
Oral cavity	46	63	14	58	32	65	12.284	0.584
Nasopharynx	2	3	1	4	1	2
Oropharynx	2	3	0	0	2	4
Hypopharynx	3	4	1	4	2	4
Larynx	7	10	2	8	5	10
Skin	8	11	3	13	5	10
Paranasal sinuses	2	2	1	4	2	4
Type of tumor (n, %)
Primary	56	77	17	71	39	80	1.019	0.601
Recurrent	11	15	4	17	7	14
Second primary	6	8	3	13	3	6
TNM Stage (n, %)
I	8	11	5	21	3	6	3.708	0.295
II	19	26	5	21	14	29
III	14	19	4	17	10	20
IV	32	44	10	42	22	45
Low Muscle strength (n, %)
No	40	55	0	0	40	82	43.340	0.000
Yes	33	45	24	100	9	18
Low SMI (n, %)
No	15	21	0	0	15	31	9.247	0.002
Yes	58	79	24	100	34	69
Frailty Fried criteria (n, %)
No	52	71	10	42	42	86	15.253	0.000
Yes	21	29	14	58	7	14
Frailty GFI (n, %)
No	35	50	9	38	26	53	1.563	0.211
Yes	38	52	15	63	23	47
Frailty CGA (n, %)
No	34	46	7	29	27	55	4.355	0.037
Yes	39	54	17	71	22	45

BM body mass index, MUST malnutrition universal screening tool, SMI skeletal muscle index, GFI groningen frailty indicator, CGA comprehensive geriatric assessment